Thromb Haemost 2010; 104(03): 531-533
DOI: 10.1160/TH09-12-0860
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

A splice variant of ADAMTS13 is expressed in human hepatic stellate cells and cancerous tissues

Noam Shomron#
1   Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Nobuko Hamasaki-Katagiri#
2   Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA
,
Ryan Hunt
2   Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA
,
Klilah Hershko
2   Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA
,
Elie Pommier
2   Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA
,
S. Geetha
2   Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA
,
Adam Blaisdell
2   Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA
,
Andrew Marple
3   Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
,
Isabella Roma
3   Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
,
Jordan Newell
2   Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA
,
Courtni Allen
2   Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA
,
Scott Friedman
4   Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York, USA
,
Chava Kimchi-Sarfaty
2   Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA
› Author Affiliations
Further Information

Publication History

Received: 23 December 2009

Accepted after major revision: 06 May 2010

Publication Date:
23 November 2017 (online)

Summary

Although ADAMTS13, the von Willebrand factor (VWF)-cleaving protease, is expressed in a range of tissues, the physiological significance of tissue-specific ADAMTS13 alternative splicing isoforms have yet to be clarified. Screening a panel of human tissues and cell lines revealed a spliced ADAMTS13 transcript in hepatic stellate cells and a hepatoma cell line that retains the 25th intron. A nonsense codon within the intron truncates the protease, which gains 64 novel amino acids in lieu of both CUB domains. This isoform, while retaining VWF-cleaving capability, accumulates intracellularly and its biological inaccessibility may prevent its participation in regulating haemostasis and other physiologic functions.

# These authors contributed equally to the research in this manuscript.


 
  • References

  • 1 Levy GG, Nichols WC, Lian EC. et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488-494.
  • 2 Tsai HM. Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura. J Thromb Haemost 2003; 1: 2038-2040.
  • 3 Majerus EM, Anderson PJ, Sadler JE. Binding of ADAMTS13 to von Willebrand factor. J Biol Chem 2005; 280: 21773-21778.
  • 4 Banno F, Kaminaka K, Soejima K. et al. Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease. J Biol Chem 2004; 279: 30896-30903.
  • 5 Shang DZ, Zheng XW, Niiya M. et al. Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts. Blood 2006; 108: 2207-2215.
  • 6 Brennan SO, Homer VM, Davis RL. et al. Hypofibrinogenaemia associated with common gamma 82Ala -> Gly mutation is not mediated by altered mRNA splicing. Thromb Haemost 2006; 96: 535-537.
  • 7 Censarek P, Steger G, Paolini C. et al. Alternative splicing of platelet cyclooxygenase-2 mRNA in patients after coronary artery bypass grafting. Thromb Haemost 2007; 98: 1309-1315.
  • 8 Zheng XL, Chung D, Takayama TK. et al. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 2001; 276: 41059-41063.
  • 9 Uemura M, Tatsumi K, Matsumoto M. et al. Localization of ADAMTS 13 to the stellate cells of human liver. Blood 2005; 106: 922-924.
  • 10 Xu L, Hui AY, Albanis E. et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 2005; 54: 142-151.
  • 11 Geetha S, Allen CE, Hunt RC. et al. Detection of Intracellular ADAMTS13, a Secreted Zinc-Metalloprotease, via Flow Cytometry. Cytometry Part A 2009; 75A: 675-681.
  • 12 Sauna ZE, Okunji C, Hunt RC. et al. Characterization of conformation-sensitive antibodies to ADAMTS13, the von Willebrand cleavage protease. Plos One 2009; 4: e6506.
  • 13 Yeo G, Burge CB.. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 2004; 11: 377-394.
  • 14 Ishikawa Y, Wirz J, Vranka JA. et al. Biochemical Characterization of the Prolyl 3-Hydroxylase 1 Cartilage-associated Protein Cyclophilin B Complex. J Biol Chem 2009; 284: 17641-17647.
  • 15 Goren A, Ram O, Amit M. et al. Comparative analysis identifies exonic splicing regulatory sequences – The complex definition of enhancers and silencers. Mol Cell 2006; 22: 769-781.
  • 16 Pimanda JE, Maekawa A, Wind T. et al. Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13. Blood 2004; 103: 627-629.
  • 17 Kim E, Goren A, Ast G. Insights into the connection between cancer and alternative splicing. Trends Genetics 2008; 24: 7-10.
  • 18 Donati MB. Cancer and Thrombosis. Haemostasis 1994; 24: 128-131.